| Literature DB >> 35381048 |
Abeni Beshiru1,2, Anthony I Okoh3,4, Etinosa O Igbinosa1,2,4.
Abstract
The study aimed to recover diarrheagenic Escherichia coli strains from processed ready-to-eat (RTE) foods in Yenagoa, Nigeria and characterize them using culture-based and molecular methods. Three hundred RTE food samples were collected randomly from different food outlets between February 2021 and August 2021 and assessed for the occurrence of E. coli using standard bacteriological procedures. The virulence factor formation and antibiotic susceptibility profile of the isolates was carried out using standard microbiological procedures. Polymerase chain reaction (PCR) was used to confirm the identity of the isolates via specific primers and further used to assay the diarrheagenic determinants of the E. coli isolates. The prevalence of E. coli positive samples based on the proliferation of E. coli on Chromocult coliform agar forming purple to violet colonies was 80(26.7%). The population density of E. coli from the RTE foods ranged from 0-4.3 × 104 ± 1.47 CFU/g. The recovered E. coli isolates (n = 62) were resistant to antibiotics in different proportions such as ampicillin 62(100%), aztreonam 47(75.81%) and chloramphenicol 43(69.35%). All the recovered E. coli isolates were resistant to ≥ 2 antibiotics. The multiple antibiotic-resistant index (MARI) ranged from 0.13-0.94 with 47(75.8%) of isolates having MARI >2. A total of 48(77.4%) of the isolates were multidrug-resistant (MDR). The proportion of extracellular virulence factor formation is as follows: protease 12(19.35%), curli 39(62.9%), cellulose 21(33.89%), ornithine decarboxylase 19(30.65%) and aesculin hydrolysis 14(22.58%). The overall proportion of diarrheagenic E. coli was 33/62(53.2%). The distributions of typical diarrheagenic E. coli includes: tETEC 9(14.5%), tEPEC 13(20.9%), tEAEC 6(9.7%), tEIEC 2(3.2%) and tEHEC 3(4.8%). The proportions of atypical strains include aETEC 10(16.1%), aEAEC 5(8.1%), aEPEC 1(1.6%) and aEIEC 3(4.8%). This study demonstrated that some RTE foods sold in Yenagoa, Nigeria, are contaminated and constitute a probable human health hazard. Thus, there is a need for intensive surveillance of this isolate in RTE foods variety to spot evolving AMR phenotypes and avert food-borne infections.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35381048 PMCID: PMC8982850 DOI: 10.1371/journal.pone.0266059
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Prevalence and E. coli counts from RTE foods.
| Type of sample collected | Number of samples examined | Prevalence of | The population cell density of |
|---|---|---|---|
| CFU/g | |||
| Oil and garri soup | 17 | 7(41.2) | 4.6 × 102 ± 1.04b |
| Cocoyam soup | 18 | 9(50) | 2.1 × 103 ± 1.20c |
| Pepper soup | 17 | 1(5.9) | 1.6 × 101 ± 0.10a |
| Plantain porridge | 15 | 2(13.3) | 5.4 × 102 ± 1.61b |
| Yam porridge | 19 | 3(15.8) | 4.8 × 102 ± 1.06b |
| Fried beans | 15 | 2(13.3) | 3.1 × 102 ± 1.23b |
| Porage beans | 18 | 4(22.2) | 2.5 × 102 ± 1.42b |
| Jollof rice | 18 | 6(33.3) | 6.1 × 103 ± 1.36c |
| Fried rice | 15 | 2(13.3) | 2.2 × 101 ± 0.04a |
| Banga rice | 15 | 1(6.7) | 1.7 × 101 ± 0.02a |
| Coconut rice | 15 | 3(20) | 3.8 × 102 ± 0.07b |
| Bitter leave soup | 17 | 2(11.8) | 3.4 × 101 ± 1.09a |
| Okazi soup | 18 | 8(44.4) | 2.2 × 103 ± 1.19c |
| Vegetable soup | 18 | 11(61.1) | 4.3 × 104 ± 1.47d |
| Melon soup | 18 | 10(55.6) | 2.8 × 103 ± 1.24c |
| Okro soup | 15 | 6(40) | 3.6 × 103 ± 0.19c |
| Ogbono soup | 15 | 0 | - |
| Banga soup | 17 | 3(17.6) | 3.4 × 101 ± 0.18a |
| Total | 300 | 80(26.7) |
Legend: Mean population cell density is expressed in mean ± standard deviation of the mean. Mean with significant difference carry different alphabets
Antimicrobial susceptibility profile of the E. coli isolates.
| Antimicrobial class | Antibiotics | |||
|---|---|---|---|---|
| Sensitive | Intermediate | Resistance | ||
| β-Lactam combination agents | Ampicillin/sulbactam (10/10 μg) | 6(9.68) | 19(30.65) | 37(59.68) |
| Amoxicillin-clavulanate (20/10 μg) | 9(14.51) | 24(38.71) | 29(46.77) | |
| Penicillins | Ampicillin (10 μg) | 0 | 0 | 62(100) |
| Aminoglycosides | Gentamicin (10 μg) | 33(53.23) | 20(32.26) | 9(14.51) |
| Streptomycin (10 μg) | 32(51.61) | 14(22.58) | 16(25.81) | |
| Carbapenems | Imipenem (10 μg) | 61(98.39) | 1(1.61) | 0 |
| Cephalosporins | Cefotaxime (30 μg) | 9(14.52) | 19(30.65) | 34(54.84) |
| Ceftazidime (30 μg) | 8(12.90) | 22(35.48) | 31(50) | |
| Quinolones | Nalidixic acid (30 μg) | 5(8.07) | 28(45.16) | 29(46.77) |
| Ciprofloxacin (5 μg) | 5(8.07) | 19(30.65) | 38(61.29) | |
| Phenicols | Chloramphenicol (30 μg) | 6(9.68) | 13(20.97) | 43(69.35) |
| Folate pathway inhibitor | Trimethoprim-sulfamethoxazole (1.25/23.75 μg) | 24(38.71) | 17(27.42) | 21(33.87) |
| Tetracyclines | Tetracycline (30 μg) | 10(16.13) | 13(20.97) | 39(62.90) |
| Macrolides | Azithromycin (15 μg) | 26(41.94) | NA | 36(58.06) |
| Monobactam | Aztreonam (30 μg) | 6(9.68) | 21(33.87) | 47(75.81) |
| Nitrofurans | Nitrofurantoin (300 μg) | 52(83.87) | 7(11.29) | 3(4.84) |
Multidrug resistance (MDR) and multiple antibiotic resistance index (MARI) profile of the E. coli isolates.
| N | N | Resistance phenotypes | N | MARI |
|---|---|---|---|---|
| 11 | 15 | AZMR, AZTR, TETR, CHLR, CIPR, NALR, CAZR, CTXR, AMPR, AMSR, AMCR, STXR, NITR, STRR, GENR | 1(1.6) | 0.94 |
| 10 | 13 | AZMR, AZTR, TETR, CHLR, CIPR, NALR, CAZR, CTXR, AMPR, AMSR, AMCR, STXR, STRR | 10(16.1) | 0.81 |
| 9 | 12 | AZMR, AZTR, TETR, CHLR, CIPR, NALR, CAZR, CTXR, AMPR, AMSR, AMCR, NITR | 2(3.2) | 0.75 |
| 8 | 11 | AZMR, AZTR, TETR, CHLR, CIPR, NALR, CAZR, CTXR, AMPR, AMSR, AMCR | 20(32.3) | 0.69 |
| 8 | 9 | AZMR, AZTR, TETR, CHLR, CIPR, CAZR, CTXR, AMPR, AMSR | 8(12.9) | 0.56 |
| 6 | 7 | AMPR, NALR, CIPR, CHLR, TETR, AZTR, AZMR | 2(3.2) | 0.44 |
| 5 | 6 | AMPR, GENR, STRR, CHLR, AZTR, AZMR | 2(3.2) | 0.38 |
| 3 | 4 | AMSR, AMCR, AMPR, AZMR | 3(4.8) | 0.25 |
Legend: AMS: Ampicillin/sulbactam (10/10 μg), AMC: Amoxicillin-clavulanate (20/10 μg), AMP: Ampicillin (10 μg), GEN: Gentamicin (10 μg), STR: Streptomycin (10 μg), IMI: Imipenem (10 μg), CTX: Cefotaxime (30 μg), CAZ: Ceftazidime (30 μg), NAL: Nalidixic acid (30 μg), CIP: Ciprofloxacin (5 μg), CHL: Chloramphenicol (30 μg), STX: Trimethoprim-sulfamethoxazole (1.25/23.75 μg), TET: Tetracycline (30 μg), AZT: Azithromycin (15 μg), AZM: Aztreonam (30 μg), NIT: Nitrofurantoin (300 μg)
Fig 1Extracellular virulence factor formation of the E. coli isolates.
Fig 2Diarrheagenic determinants of E. coli from processed RTE foods.
Fig 3Typical diarrheagenic E. coli from processed RTE foods.